Publications by authors named "Sadegh Rostaminasab"
Int J Biol Macromol
December 2024
Article Synopsis
- Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive characteristics, leading researchers to explore innovative delivery methods for medications.
- Human serum albumin (HSA) was used to encapsulate Lapatinib (LAP), a drug effective against TNBC, improving its solubility and targeting capabilities in tumor environments.
- The combination of HSA-LAP with a VEGFR-targeting peptide (VGB3) significantly enhanced anti-cancer effects, including better tumor inhibition and survival rates in animal models, indicating a compelling strategy for TNBC treatment.
